Yesterday
J&J, Legend withdraw ASH abstract assessing Carvykti against Gilead, Arcellx’s rival CAR-T FiercePharma16:43 12-Nov-25
March Bio’s MB‑105 gains FDA RMAT for CD5+ T‑cell lymphoma Pharmaceutical Technology09:12 12-Nov-25
Curocell earns ISO 45001 certification, reinforcing safety standards in CAR-T manufacturing Korea Biomedical Review08:16 12-Nov-25
In the last 7 days
Council asked to support Dublin cancer treatment pathway Northern Ireland World11:49 10-Nov-25
Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the… PR Newswire (Press Release)08:36 10-Nov-25
Early Clinical Success of Allogeneic CAR-T Therapies Might Change The Case For Investing In CARsgen Therapeutics… Simply Wall St00:06 9-Nov-25
A Look at HBM Holdings (SEHK:2142) Valuation After Latest CAR-T Therapy and AI Collaboration Advances Simply Wall St15:21 7-Nov-25
Imugene prepares pivotal azer-cel trial with FDA - ICYMI Proactive Investors (Australia)06:58 7-Nov-25
Korean biotechs to unveil CAR-T, ADC, and NK-cell data at US hematology meeting Korea Biomedical Review03:11 7-Nov-25
Victoria cancer team builds next-gen ‘sport CARs’ to take on solid tumours Sooke News Mirror02:33 7-Nov-25
EBV-Associated Lymphoproliferative Disease Post-CAR-T Cell Therapy Newswise (Press Release)09:14 6-Nov-25
In the last month
HBM Holdings Partners with Umoja Biopharma for CAR-T Cell Development TipRanks12:14 5-Nov-25
Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo… PR Newswire (Press Release)12:09 5-Nov-25
New ‘plug-and-play’ cell design could revolutionize cancer immunotherapy University of Chicago News16:08 4-Nov-25
Grit Biotherapeutics Invited to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo… PR Newswire (Press Release)13:21 4-Nov-25
STAT Plus: Jennifer Doudna spinoff aims to turn patients’ immune cells into CAR-T fighters with … STAT13:09 4-Nov-25
Curocell inks supply deal with ProBio for viral vectors key to CAR-T production Korea Biomedical Review02:35 4-Nov-25
Imugene abstract on azer-cel selected for oral presentation at ASH 2025 Proactive Investors (US)23:35 3-Nov-25
Galapagos to Present Promising CAR-T Cell Therapy Data at ASH 2025 TipRanks22:33 3-Nov-25
AAVivo, Inc. to Present at Society for Immunotherapy of Cancer 2025 PR Newswire (Press Release)21:06 3-Nov-25
Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today> Benzinga17:20 3-Nov-25
Caribou Biosciences Reports Positive Phase 1 Data For Allogeneic car-T Therapy Vispa-cel; Stock Up RTT News14:30 3-Nov-25
CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B PR Newswire (Press Release)14:25 3-Nov-25
Qihan Biotech Announces Multiple Presentations at the 2025 American Society of Hematology (ash) … Business Wire (Press Release)14:10 3-Nov-25
STAT Plus: Caribou’s off-the-shelf CAR-T therapy shows promise in lymphoma study STAT12:03 3-Nov-25
Clinical momentum defines Imugene’s September quarter Proactive Investors (Australia)01:40 3-Nov-25
On-target off-tumor toxicity of claudin18.2-directed car-T cells in preclinical models Nature.com10:23 1-Nov-25
IASO Bio partners with GC Cell to bring CAR-T therapy to Korea BioSpectrum Asia07:00 31-Oct-25
CAR-T Therapy Leads to Myasthenia Gravis Improvements Medpage Today15:41 30-Oct-25
Fundamental challenges and cutting-edge strategies in developing new GBM CAR-T therapies News-Medical.Net11:11 30-Oct-25
GC Cell introduces multiple myeloma CAR-T therapy from China’s IASO Biotech Korea Biomedical Review06:46 30-Oct-25
CD28-mediated linear and parallel costimulatory signaling cooperatively regulate car-T cell functions via car-CD28… Nature.com10:24 29-Oct-25
Hemogenyx shares rise after safety board backs next trial phase for CAR-T therapy Proactive Investors (US)10:04 29-Oct-25
IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea PR Newswire (Press Release)09:01 29-Oct-25
Vaxcellbio unveils study analyzing CAR-T therapy’s limitations in solid tumors Korea Biomedical Review07:28 29-Oct-25
Hemogenyx Pharmaceuticals Advances CAR-T Therapy Trial with DSMB Approval TipRanks07:15 29-Oct-25
[ESMO 2025] CellabMED made phase 1 oral presentation on CAR-T targeting IL13Rα2 Korea Biomedical Review03:23 29-Oct-25
Lantern Pharma Presents LP-284 Clinical Data at 25th Ll&M Congress, Highlighting Complete… Business Wire (Press Release)12:49 28-Oct-25
Novel computational platform can design synthetic protein receptors from scratch News-Medical.Net12:24 28-Oct-25
Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment TipRanks21:27 27-Oct-25
Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis TipRanks19:05 27-Oct-25
Kyverna Therapeutics Advances with Promising CAR-T Therapy for Stiff Person Syndrome TipRanks17:43 27-Oct-25
Caribou Biosciences Advances CRISPR-Edited CAR-T Therapy in Lymphoma Study TipRanks17:43 27-Oct-25
STAT Plus: CAR-T therapies from Cabaletta, Bristol Myers Squibb induce remissions in patients… STAT11:09 27-Oct-25
Scientists Create “Velcro Bomb” That Enables Immune Cells to Attack Solid Cancer Tumors ZME Science22:23 24-Oct-25
Ewha Blood Cancer Hospital accelerates refractory blood cancer care Korea Biomedical Review08:36 24-Oct-25
AdAlta Completes Cash Settlement with NLSC, Advances CAR-T Strategy TipRanks01:21 24-Oct-25
Collagen-binding Il-12-armoured STEAP1 car-T cells reduce toxicity and treat prostate cancer in mouse models Nature.com01:17 23-Oct-25
The Evolving Oncology Landscape PharmTech.com19:05 22-Oct-25
Blood Publishes Promising Results of IASO Bio's Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory… PR Newswire (Press Release)12:42 22-Oct-25
Epigenetic editing enables safer and more effective T cell therapies News-Medical.Net19:36 21-Oct-25
IASO Bio Announces Approval of Clinical Trial Notification for its BCMA CAR-T Product in Japan PR Newswire (Press Release)11:48 21-Oct-25
Curocell secures approval to begin phase 2 CAR-T therapy trial for adult ALL in Korea Korea Biomedical Review03:30 21-Oct-25
Who Knew? Autoimmunity Might Actually Benefit Some Cancer Patients Medpage Today21:56 20-Oct-25
AbelZeta Announces Late-Breaking Poster Presentation at ACR Convergence 2025 of First-in-Human… PR Newswire (Press Release)13:31 20-Oct-25
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for… PR Newswire (Press Release)07:08 19-Oct-25
Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing Zacks18:25 17-Oct-25
A tumor-on-a-chip for in vitro study of car-T cell immunotherapy in solid tumors Nature.com10:59 17-Oct-25
Tumor-on-chip models of car-T cell therapy Nature.com10:19 17-Oct-25
Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene… PR Newswire (Press Release)13:47 16-Oct-25
Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell… PR Newswire (Press Release)13:05 15-Oct-25
KFSHRC Achieves Breakthrough in Gene Therapy with Local Production of CAR-T Cells DT News16:37 14-Oct-25
'CAR-T therapy’s real-world cure rate only half of early expectations' Korea Biomedical Review08:05 14-Oct-25
Curocell to help Turkey build first CAR-T production base through partnership with Biruni Korea Biomedical Review07:24 14-Oct-25

      
            
      
    view more headlines
   
      
      
      
12 Nov 16:43
   
About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.
CAR-T

Latest News

About our CAR-T news

Cancer Top Stories

Health Top Stories

UK Top Stories

World Top Stories
